Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

IMPORTANCE: Initial results of this intergroup trial of imatinib for patients with metastatic/ unresectable GIST were reported in 2008 (http://www.ncbi.nlm.nih.gov/pubmed/18235122). Updated results reported here show long-term survival with a significant subset of patients surviving 10 or more years...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Oncol
Päätekijät: Heinrich, Michael C., Rankin, Cathryn, Blanke, Charles D., Demetri, George D., Borden, Ernest C., Ryan, Christopher W., von Mehren, Margaret, Blackstein, Martin E., Priebat, Dennis A., Tap, William D., Maki, Robert G., Corless, Christopher L., Fletcher, Jonathan A., Owzar, Kouros, Crowley, John J., Benjamin, Robert S., Baker, Laurence H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727908/
https://ncbi.nlm.nih.gov/pubmed/28196207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6728
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia